Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanjay Goel

Showing results (51-60 of 182) with videos related to

Pageof 19
Sort By:
Medrxiv : the Preprint Server for Health Sciences|September 30, 2020
Increased incidence of thrombosis in a cohort of cancer patients with COVID-19Phaedon D Zavras, Vikas Mehta, Sanjay Goel, et al.
Cancer Medicine|February 28, 2021
Racial/ethnic disparities in early-onset colorectal cancer: implications for a racial/ethnic-specific screening strategyAna R Acuna-Villaorduna, Juan Lin, Mimi Kim, et al.
Investigational New Drugs|January 7, 2019
Sensitization of colorectal cancer to irinotecan therapy by PARP inhibitor rucaparibTitto Augustine, Radhashree Maitra, Jinghang Zhang, et al.
Expert Review of Anticancer Therapy|June 25, 2003
Erlotinib (Tarceva): a promising drug targeting epidermal growth factor receptor tyrosine kinaseAnca M Bulgaru, Sridhar Mani, Sanjay Goel, et al.
Journal of Cardiothoracic and Vascular Anesthesia|July 30, 2011
Intraoperative detection of a stuck bioprosthetic mitral valve leaflet causing severe mitral regurgitationSanjay Goel, Neeraj Monga, Sanjoy Majhi, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Patterns of Response and Progression to ImmunotherapyEdith Borcoman, Amara Nandikolla, Georgina Long, et al.
Oncotarget|April 20, 2017
Toll like receptor 3 as an immunotherapeutic target for KRAS mutated colorectal cancerRadhashree Maitra, Titto Augustine, Yitzchak Dayan, et al.
Cancers|August 1, 2020
Protein Arginine Methyltransferase 5 as a Therapeutic Target for <i>KRAS</i> Mutated Colorectal CancerDavid Shifteh, Tzuriel Sapir, Moshe Pahmer, et al.
Vaccines|October 27, 2022
Prevalence and Assessment of Factors Associated with COVID-19 Vaccine Hesitancy in an Ethnic Minority Oncology Patient PopulationMatthew Lee, Emily Miao, Bruce Rapkin, et al.
Current Issues in Molecular Biology|July 26, 2024
Erlotinib Treatment in Colorectal Cancer Suppresses Autophagy Based on <i>KRAS</i> MutationAlexander Siegman, Aaron Shaykevich, Danbee Chae, et al.
Pageof 19

Showing results (51-60 of 182) with videos related to

Sort By:
Pageof 19
Medrxiv : the Preprint Server for Health Sciences|September 30, 2020
Increased incidence of thrombosis in a cohort of cancer patients with COVID-19Phaedon D Zavras, Vikas Mehta, Sanjay Goel, et al.
Cancer Medicine|February 28, 2021
Racial/ethnic disparities in early-onset colorectal cancer: implications for a racial/ethnic-specific screening strategyAna R Acuna-Villaorduna, Juan Lin, Mimi Kim, et al.
Investigational New Drugs|January 7, 2019
Sensitization of colorectal cancer to irinotecan therapy by PARP inhibitor rucaparibTitto Augustine, Radhashree Maitra, Jinghang Zhang, et al.
Expert Review of Anticancer Therapy|June 25, 2003
Erlotinib (Tarceva): a promising drug targeting epidermal growth factor receptor tyrosine kinaseAnca M Bulgaru, Sridhar Mani, Sanjay Goel, et al.
Journal of Cardiothoracic and Vascular Anesthesia|July 30, 2011
Intraoperative detection of a stuck bioprosthetic mitral valve leaflet causing severe mitral regurgitationSanjay Goel, Neeraj Monga, Sanjoy Majhi, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Patterns of Response and Progression to ImmunotherapyEdith Borcoman, Amara Nandikolla, Georgina Long, et al.
Oncotarget|April 20, 2017
Toll like receptor 3 as an immunotherapeutic target for KRAS mutated colorectal cancerRadhashree Maitra, Titto Augustine, Yitzchak Dayan, et al.
Cancers|August 1, 2020
Protein Arginine Methyltransferase 5 as a Therapeutic Target for <i>KRAS</i> Mutated Colorectal CancerDavid Shifteh, Tzuriel Sapir, Moshe Pahmer, et al.
Vaccines|October 27, 2022
Prevalence and Assessment of Factors Associated with COVID-19 Vaccine Hesitancy in an Ethnic Minority Oncology Patient PopulationMatthew Lee, Emily Miao, Bruce Rapkin, et al.
Current Issues in Molecular Biology|July 26, 2024
Erlotinib Treatment in Colorectal Cancer Suppresses Autophagy Based on <i>KRAS</i> MutationAlexander Siegman, Aaron Shaykevich, Danbee Chae, et al.
Pageof 19